Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Medtronic
Colorcon
Dow
Moodys
Boehringer Ingelheim

Last Updated: June 26, 2022

CLINICAL TRIALS PROFILE FOR LOPERAMIDE HYDROCHLORIDE


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Loperamide Hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00003057 ↗ Octreotide Compared With Loperamide Hydrochloride for Chemotherapy-Related Diarrhea in Patients With Colorectal Cancer Completed Cancer and Leukemia Group B Phase 3 1996-11-01 RATIONALE: Drugs such as octreotide and loperamide hydrochloride use different ways to relieve the diarrhea caused by chemotherapy. PURPOSE: Randomized phase III trial to compare the effectiveness of octreotide with loperamide hydrochloride for the treatment of chemotherapy-related diarrhea in patients who have colorectal cancer.
NCT00003057 ↗ Octreotide Compared With Loperamide Hydrochloride for Chemotherapy-Related Diarrhea in Patients With Colorectal Cancer Completed National Cancer Institute (NCI) Phase 3 1996-11-01 RATIONALE: Drugs such as octreotide and loperamide hydrochloride use different ways to relieve the diarrhea caused by chemotherapy. PURPOSE: Randomized phase III trial to compare the effectiveness of octreotide with loperamide hydrochloride for the treatment of chemotherapy-related diarrhea in patients who have colorectal cancer.
NCT00003057 ↗ Octreotide Compared With Loperamide Hydrochloride for Chemotherapy-Related Diarrhea in Patients With Colorectal Cancer Completed Southwest Oncology Group Phase 3 1996-11-01 RATIONALE: Drugs such as octreotide and loperamide hydrochloride use different ways to relieve the diarrhea caused by chemotherapy. PURPOSE: Randomized phase III trial to compare the effectiveness of octreotide with loperamide hydrochloride for the treatment of chemotherapy-related diarrhea in patients who have colorectal cancer.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Loperamide Hydrochloride

Condition Name

Condition Name for Loperamide Hydrochloride
Intervention Trials
Diarrhea 11
Fecal Incontinence 7
Breast Cancer 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Loperamide Hydrochloride
Intervention Trials
Diarrhea 26
Breast Neoplasms 12
Fecal Incontinence 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Loperamide Hydrochloride

Trials by Country

Trials by Country for Loperamide Hydrochloride
Location Trials
United States 225
Spain 13
Canada 10
Mexico 7
China 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Loperamide Hydrochloride
Location Trials
California 14
Texas 13
Florida 13
New York 12
North Carolina 11
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Loperamide Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Loperamide Hydrochloride
Clinical Trial Phase Trials
Phase 4 10
Phase 3 11
Phase 2/Phase 3 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Loperamide Hydrochloride
Clinical Trial Phase Trials
Completed 35
Recruiting 9
Terminated 9
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Loperamide Hydrochloride

Sponsor Name

Sponsor Name for Loperamide Hydrochloride
Sponsor Trials
Puma Biotechnology, Inc. 4
Eli Lilly and Company 3
Naval Medical Research Center 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Loperamide Hydrochloride
Sponsor Trials
Other 88
Industry 46
U.S. Fed 10
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Johnson and Johnson
Moodys
Harvard Business School
Boehringer Ingelheim
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.